Accutane is the original brand name for isotretinoin, a powerful prescription medication used to treat severe acne. It was approved by the FDA on May 7, 1982, and manufactured by the Swiss pharmaceutical company Hoffmann-La Roche. Though the Accutane brand itself was discontinued in 2009, the name stuck and is still widely used as shorthand for isotretinoin, which remains available under several generic versions.
Where the Name Comes From
The name “Accutane” is a branded trade name created by Hoffmann-La Roche, not a medical or scientific term. It doesn’t have a literal dictionary definition. The drug’s actual chemical name, isotretinoin, tells you more: it’s a synthetic form of vitamin A, belonging to a class of compounds called retinoids. Hoffmann-La Roche synthesized it in the 1960s and patented it in 1969, though it took over a decade of research before the FDA cleared it for use in patients with severe nodular acne that hadn’t responded to other treatments.
What Isotretinoin Actually Does
Isotretinoin works by targeting nearly every factor that causes acne. It dramatically shrinks the oil glands in your skin, reducing the amount of sebum they produce. It also changes how skin cells behave, slowing the buildup of dead cells inside pores that leads to clogging. On top of that, it has anti-inflammatory effects that help calm the deep, painful cysts and nodules characteristic of severe acne.
At the molecular level, isotretinoin and its breakdown products activate receptors in cell nuclei that regulate how cells grow and specialize. This is what makes it so effective but also why it carries significant risks, since those same cellular processes matter throughout the body, not just in the skin.
Who It’s Prescribed For
Isotretinoin is reserved for severe, disfiguring nodular acne. It’s not a first-line treatment. You’ll typically only be prescribed it after other approaches, including topical treatments and oral antibiotics, have failed. For women who can become pregnant, the criteria are even stricter: other forms of treatment must have been tried first.
A standard course of treatment aims for a cumulative dose of 120 to 150 mg per kilogram of body weight, which usually means taking it daily for about five to six months. Some patients may need higher cumulative doses to achieve the best results.
How Well It Works
Isotretinoin is the most effective acne treatment available. Most patients see dramatic clearing during a single course. However, it’s not always permanent. Relapse rates in published studies range from about 10% to 60%, depending on the dosing approach, how long patients were followed, and the severity of acne at the start. In one study tracking 142 patients for two years, the relapse rate was 15 events per 100 person-years of follow-up. When acne does return, it’s often milder and may respond to treatments that didn’t work before. Some people need a second course.
Common Side Effects
Dryness is the hallmark side effect. Nearly everyone on isotretinoin experiences dry, cracked lips, dry skin, and dry eyes. The inside of the nose dries out too, which can lead to nosebleeds. These effects are directly related to the drug’s mechanism: it’s suppressing oil production throughout your body, not just on your face.
Joint and muscle aches are common, especially during physical activity. Some people notice increased sensitivity to the sun. Most of these side effects are dose-dependent, meaning they’re more pronounced at higher daily doses, and they resolve after treatment ends.
The Pregnancy Risk
Isotretinoin is one of the most well-documented causes of birth defects in modern medicine. Exposure during the first trimester can cause severe malformations including heart defects, cleft palate, abnormalities of the ears and jaw, and certain brain malformations. In one prospective study of 36 pregnancies exposed to isotretinoin, eight ended in spontaneous miscarriage and five resulted in infants or stillbirths with major malformations. The relative risk for these specific birth defects was more than 25 times higher than in unexposed pregnancies.
Because of this, every patient, prescriber, and pharmacy in the United States must be registered in a federal safety program called iPLEDGE before isotretinoin can be prescribed or dispensed. Patients who can become pregnant are required to use two forms of contraception and undergo regular pregnancy testing throughout treatment. The first pregnancy test must be done in a medical setting, though follow-up tests during treatment may be completed at home if the prescriber allows it. Prescriptions must be picked up within a seven-day window, or a new pregnancy test is required.
Brand vs. Generic Today
Roche stopped selling Accutane in June 2009. Generics had been available since 2002 and had captured over 95% of the market, making the brand commercially unviable. Today, isotretinoin is sold under several generic labels. The medication itself is identical in active ingredient and works the same way. If someone says they’re “on Accutane,” they’re almost certainly taking a generic version of isotretinoin, but the old brand name remains the common way people refer to the drug.